Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats

Dasatinib (DAS) is a narrow therapeutic index drug and novel oral multitarget inhibitor of tyrosine kinase and approved for the first-line therapy for chronic myelogenous leukemia (CML) and Philadelphia chromosome (Ph + ) acute lymphoblastic leukemia (ALL). DAS, a known potent substrate of cytochrom...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahid, Mudassar, Ahmad, Ajaz, Raish, Mohammad, Bin Jardan, Yousef A, Alkharfy, Khalid M., Ahad, Abdul, Abul Kalam, Mohd, Ahmad Ansari, Mushtaq, Iqbal, Muzaffer, Ali, Naushad, Al-Jenoobi, Fahad I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582055/
https://www.ncbi.nlm.nih.gov/pubmed/37860687
http://dx.doi.org/10.1016/j.jsps.2023.101819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582055/
https://www.ncbi.nlm.nih.gov/pubmed/37860687
http://dx.doi.org/10.1016/j.jsps.2023.101819

Ejemplares similares